Pinsent Masons advises Mynaric AG on its IPO

31 Oct 2017 | 01:01 pm |

International law firm Pinsent Masons has advised Mynaric AG on its €27.3 million IPO on the Frankfurt Stock Exchange.

Mynaric AG, a specialist for innovative laser-based communications networks in the air and in space, has successfully been listed on the stock exchange.

The issuance price was at the upper end of the bookbuilding span. The IPO was four times oversubscribed. Mynaric AG listed in the new scale segment of the Frankfurt stock exchange on 30 October 2017.

The proceeds of the issue will be used for the planned growth of the laser technology provider. Mynaric aims to become an international leader in the field of dynamic communication networks in the aerospace industry.

Hauck & Aufhäuser accompanied the IPO as Sole Global Coordinator and Bookrunner.

Pinsent Masons' Munich team advised Mynaric AG throughout the IPO process, including the conversion of the company into a stock corporation fit for the capital markets, the drafting of the required prospectus including the advice on the regulatory clearance of the prospectus and all other legal aspects in relation to the implementation of the placing and the IPO of the company.

Key Contacts

Thomas Mayrhofer

Thomas Mayrhofer

Rechtsanwalt, Partner, Head of Corporate and M&A, Germany

View Profile

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts